Background: Resistance to the antimalarial drug sulfadoxine-pyrimethamine (SP) emerged in Plasmodium falciparum fromAsia in the 1960s and subsequently spread to Africa. In Tanzania, SP use as a national policy began in 1983 as a second line to chloroquine (CQ) for the treatment of uncomplicated malaria, until August 2001 when it was approved to replace CQ as a national first line.Objective: The present study assesses the frequency of resistant dhfr and dhps alleles in Morogoro-Mvomero district in south eastern Tanzania and contrast their rate of change during 17 years of SP second line use against five years of SP first line use.Methodology: Cross sectional surveys of asymptomatic infections were carried out at the end of rainy season durin...
Intermittent preventive treatment (IPT) with sulphadoxine-pyrimethamine in vulnerable populations re...
Drug resistance negatively impacts malaria treatments, making treatment policy revision unavoidable....
A study was carried out to assess the patterns of resistance and occurrence of DHFR/DHPS genotypes o...
BACKGROUND\ud \ud Resistance to the antimalarial drug sulfadoxine-pyrimethamine (SP) emerged in Plas...
African Health Sciences 2011Background: Resistance to the antimalarial drug sulfadoxine-pyrimethamin...
Background: Resistance to the antimalarial drug sulfadoxine-pyrimethamine (SP) emerged in Plasmodium...
BACKGROUND: Sulfadoxine-pyrimethamine was first introduced for treatment of malaria in Africa during...
BACKGROUND: Sulphadoxine-pyrimethamine (SP) resistance is now widespread throughout east and souther...
Background: In Tanzania, drug-resistant malaria parasites are an increasing public health concern. B...
OBJECTIVES: To assess the extent of drug resistance in Uige through molecular genetic analysis and t...
BACKGROUND: Sulfadoxine-pyrimethamine (SP) is recommended for prophylactic treatment of malaria in p...
Malaria Journal 2011Background: Sulphadoxine-pyrimethamine (SP) resistance is now widespread through...
Sulfadoxine-pyrimethamine (SP) is recommended for prophylactic treatment of malaria in pregnancy whi...
Abstract. In January 2007, Tanzania replaced sulfadoxine-pyrimethamine (SP) with artemether-lumefant...
Ifakara Health Research and Development Centre, Ifakara, Tanzania; National Institute for Medical Re...
Intermittent preventive treatment (IPT) with sulphadoxine-pyrimethamine in vulnerable populations re...
Drug resistance negatively impacts malaria treatments, making treatment policy revision unavoidable....
A study was carried out to assess the patterns of resistance and occurrence of DHFR/DHPS genotypes o...
BACKGROUND\ud \ud Resistance to the antimalarial drug sulfadoxine-pyrimethamine (SP) emerged in Plas...
African Health Sciences 2011Background: Resistance to the antimalarial drug sulfadoxine-pyrimethamin...
Background: Resistance to the antimalarial drug sulfadoxine-pyrimethamine (SP) emerged in Plasmodium...
BACKGROUND: Sulfadoxine-pyrimethamine was first introduced for treatment of malaria in Africa during...
BACKGROUND: Sulphadoxine-pyrimethamine (SP) resistance is now widespread throughout east and souther...
Background: In Tanzania, drug-resistant malaria parasites are an increasing public health concern. B...
OBJECTIVES: To assess the extent of drug resistance in Uige through molecular genetic analysis and t...
BACKGROUND: Sulfadoxine-pyrimethamine (SP) is recommended for prophylactic treatment of malaria in p...
Malaria Journal 2011Background: Sulphadoxine-pyrimethamine (SP) resistance is now widespread through...
Sulfadoxine-pyrimethamine (SP) is recommended for prophylactic treatment of malaria in pregnancy whi...
Abstract. In January 2007, Tanzania replaced sulfadoxine-pyrimethamine (SP) with artemether-lumefant...
Ifakara Health Research and Development Centre, Ifakara, Tanzania; National Institute for Medical Re...
Intermittent preventive treatment (IPT) with sulphadoxine-pyrimethamine in vulnerable populations re...
Drug resistance negatively impacts malaria treatments, making treatment policy revision unavoidable....
A study was carried out to assess the patterns of resistance and occurrence of DHFR/DHPS genotypes o...